Since March 2021, there have been some changes in the pricing of pharmaceuticals in France, leading progressively to a somehow improved access to treatment....
CarthaGenetics is attending the SSIEM congress (Scientific Society for Inborn Errors of Metabolism) in Freiburg in Breisgau (Germany)...
For patients with rare diseases, time to access has been always the greatest challenge....
Carthagenetics is proud to be a member of ASEBIO...
Patient's voice matters in health decision. Get to know how the US and France compare....
Confused with rare disease defintion, have a look on this short note....
CarthaGenetics® team, Dr. Amir Sharaf & Dr. Guvenc Kockaya and the Econix team are glad to announce the publication of the article: "A Market Research Of Obesity And Bariatric Surgery In Turkey And Tunisia". https://lnkd.in/e8KvWxW ...
World Orphan Drug Congress has grown to become the largest and most established orphan drugs & rare diseases meeting in Europe and this year will be no exception. As a leader in Orphans Drugs Early Access Programs in Europe, Including Turkey, CarthaGenetics®, a member of the...
BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. The conference annually attracts leading deal makers from biotech, pharma and finance along with the most exciting emerging companies. As leader in Early Access Programs in Europe, Including Turkey, CarthaGenetics®, member of the Swiss Biotech...
The Embassy of India, Berne, launched the ‘Momentum in India: Swiss SMEs Programme’ (MISSP) to facilitate Swiss SMEs explore, enter, and expand in the Indian market.Tomorrow, the Embassy of India, Berne, along with the MISSP Team members, will celebrate its first anniversary by organizing an...